In this episode (in Swiss German), host Angelina Rau sits down with Barbara Meier, attorney at law at VISCHER AG and expert in tariff and healthcare law, to unpack one of the most complex yet crucial topics for digital health innovators in Switzerland — reimbursement and tariffs. They discuss how Digital Health Applications (DiGAs) — software-based medical devices such as health apps or digital therapeutics — gain access to the Swiss healthcare system. Even when approved and recognized under ...
All content for Navigating Swiss Market Access #medtech #digitalhealth is the property of Gurmit Sandhu & Angelina Rau and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
In this episode (in Swiss German), host Angelina Rau sits down with Barbara Meier, attorney at law at VISCHER AG and expert in tariff and healthcare law, to unpack one of the most complex yet crucial topics for digital health innovators in Switzerland — reimbursement and tariffs. They discuss how Digital Health Applications (DiGAs) — software-based medical devices such as health apps or digital therapeutics — gain access to the Swiss healthcare system. Even when approved and recognized under ...
Meet your co-hosts & their why | Increasing your confidence on #healthtech market acces
We will be exploring, developing a better understanding, and uncovering strategies & tactics to enhance Swiss market access (reimbursement) for digital health technologies (DHTs), including MedTech and Medical Devices. With our combined expertise in digital health technologies, we’ll invite key stakeholders to share their insights, where we will: a. discuss their challenges, opportunities, and successes in the Swiss market access ecosystem. b. delve into their pain points, c...
In this episode (in Swiss German), host Angelina Rau sits down with Barbara Meier, attorney at law at VISCHER AG and expert in tariff and healthcare law, to unpack one of the most complex yet crucial topics for digital health innovators in Switzerland — reimbursement and tariffs. They discuss how Digital Health Applications (DiGAs) — software-based medical devices such as health apps or digital therapeutics — gain access to the Swiss healthcare system. Even when approved and recognized under ...